经皮冠状动脉介入治疗(PCI)患者的中医证型分布及预后危险因素:系统评价和meta分析OA
Distribution of traditional Chinese medicine pattern types and prognostic risk factors in patients undergoing percutaneous coronary intervention(PCI):a systematic review and meta-analysis
目的 探讨经皮冠状动脉介入治疗(PCI)中医证候分布及相关风险因素,并评估现有研究的报告质量,以期为未来的标准化研究提供指导.方法 分别在PubMed、Cochrane Library和Web of Science等英文数据库,以及中国知网(CNKI)、维普(VIP)和万方数据库等中文数据库中检索PCI相关论文.论文检索的时间跨度从数据库建立至 2023年 10 月 1日.使用Stata 12 和Python(V 3.9)进行统计分析.采用观察性…查看全部>>
Objective To clarify the distribution of traditional Chinese medicine(TCM)pattern and its associated risk factors after percutaneous coronary intervention(PCI),and evaluate the re-porting quality of existing studies to guide future research standardization. Methods English databases including PubMed,Cochrane Library,and Web of Science,as well as Chinese databases including China National Knowledge Infrastructure(CNKI),China Scientific Journal Database(VIP),a…查看全部>>
李洁韵;洪磊鑫;林洁琪;夏雨墨;肖欣昂;许朝霞
上海中医药大学中医学院,上海 201203,中国||上海健康辨识与评估重点实验室,上海 201203,中国上海中医药大学中医学院,上海 201203,中国||上海健康辨识与评估重点实验室,上海 201203,中国上海中医药大学中医学院,上海 201203,中国||上海健康辨识与评估重点实验室,上海 201203,中国上海中医药大学中医学院,上海 201203,中国||上海健康辨识与评估重点实验室,上海 201203,中国上海中医药大学中医学院,上海 201203,中国||上海健康辨识与评估重点实验室,上海 201203,中国上海中医药大学中医学院,上海 201203,中国||上海健康辨识与评估重点实验室,上海 201203,中国
冠心病中医经皮冠状动脉介入治疗风险因素系统评价meta分析
Coronary heart disease(CHD)Traditional Chinese medicine(TCM)Percutaneous coronary intervention(PCI)Risk factorSystematic reviewMeta-analysis
《数字中医药（英文）》 2024 (1)
13-28,16
National Natural Science Foundation of China(82074333 and 82374336),and Shanghai Key Laboratory of Health Identification and Assessment(21DZ2271000).
评论